Ireland
--:--IST
Latest
Clinical Trials in Israel / NCT07056049
Recruiting Not applicable

The Efficacy of Additional Motor Training Dosage During the Early Stages Post Stroke on the Upper Extremity Recovery

NCT07056049 · tracked via the Priya Life Science Israel tracker
Phase
Not applicable
Started
2025-07-13
Last updated
2025-07-17

Condition(s) studied

StrokeHemiplegia and Hemiparesis

Investigational drug(s) / intervention(s)

High dosage, high intensity motor rehabilitation

High dosage, high intensity motor rehabilitation: Participants will receive additional technology-based upper extremity training for 120 min/day, 5d/w, 4 weeks.

Study summary

Intervention abstract

Background: Stroke is the leading cause of long-term disability, and the second leading cause of death in the western world. Most stroke survivors will suffer from motor and cognitive disturbances for the rest of their life, which negatively affects their normal daily life.

Despite the decline in stroke-related mortality over the past decades, the outcome of rehabilitation programs does not improve, and is predictable regardless of the program used. Still, several human and animal studies show that high capacity of training in the early stages post stroke improve motor recovery. This notion is far from being well established.

Aim: Studying the effect of high-dosage, high-intensity training program in the subacute period on upper extremity motor recovery.

Population: Stroke survivors. Study duration: 6 months. Study protocol: Participants will receive additional technology-based upper extremity training for 120 min/day, 5d/w, 4 weeks. They will be monitored pre and post training, and 6 months post-stroke. Outcome measures will include clinical, kinematic and adherence measures (see complete list in the protocol).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years * Ischemic or hemorrhagic stroke (hemispheric or brainstem) confirmed by CT or MRI * First-ever stroke or previous stroke with no upper extremity weakness * 1 week ≤ Time after stroke onset ≤ 6 weeks * Active shoulder flexion of at least 20◦ and partial wrist and/or finger active movement * Ability to provide inform consent Exclusion Criteria: * A painful shoulder limiting an active forward reach * Severe spasticity or non-neural loss of range of motion * Cognitive or communication impairments as determined by the clinical team Unstable medical conditions

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Adi Negev-Nahalat Eran Ofakim Israel Not Yet Recruiting
Adi Negev-Nahalat Eran Ofakim Israel Recruiting

More Adi Negev-Nahalat Eran trials in Israel

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07056049 on ClinicalTrials.gov ↗ ← All trials in Israel